Actions

Newsfeed Popular Local Discover Follows Blocks Bookmarks Filters Settings PowerUps Help Updates

stocktitan.net / Share Newsitem

View, share or embed this newsitem using the details below.

Stock Market News Live | StockTitan.net

@stocktitan.net/2 days2d

Lexicon Pharma Receives FDA Rejection for Diabetes Drug Zynquista, Shifts Focus to Pain Treatment Pipeline

FDA issues Complete Response Letter for Lexicon's diabetes drug Zynquista. Company pivots to promising LX9211 development for neuropathic pain, with key data expected Q1 2025.

https://newsreadery.com/go/07259f7e93e6d60fe981b3c6f1bf6322

Save

Back

Read Full Article